UBS Maintains a 'Neutral' on STR Holdings (STRI); Cutting Estimates After Q4 Review
Get Alerts STRI Hot Sheet
Price: $0.05 --0%
Rating Summary:
2 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
2 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Neutral' on STR Holdings (NYSE: STRI) price target cut from $8.50 to $6.50.
UBS analyst said, "STR sees a challenging in 1H as demand drivers have slowed due to steep FiT cuts and seasonality. STR’s 4Q11 utilization rate was 31%; however, STR generated $26M in operating cash flow in 4Q11. We believe First Solar’s recent module reliability problems in hot climates are likely not attributed to STR’s encapsulants."
"STR guided its 1Q12 Sales/EPS to $30M/$0.06 (STR’s receipt of $7.2M settlement benefit included) vs. consensus estimates of $38M/$0.07. We estimate operating break-even for STR at about $33M..." (UBS lowers FY12 EPS estimate from $0.50 to $0.30 and FY13 from $0.80 to $0.50)
For an analyst ratings summary and ratings history on STR Holdings click here. For more ratings news on STR Holdings click here.
Shares of STR Holdings closed at $6.26 yesterday.
UBS analyst said, "STR sees a challenging in 1H as demand drivers have slowed due to steep FiT cuts and seasonality. STR’s 4Q11 utilization rate was 31%; however, STR generated $26M in operating cash flow in 4Q11. We believe First Solar’s recent module reliability problems in hot climates are likely not attributed to STR’s encapsulants."
"STR guided its 1Q12 Sales/EPS to $30M/$0.06 (STR’s receipt of $7.2M settlement benefit included) vs. consensus estimates of $38M/$0.07. We estimate operating break-even for STR at about $33M..." (UBS lowers FY12 EPS estimate from $0.50 to $0.30 and FY13 from $0.80 to $0.50)
For an analyst ratings summary and ratings history on STR Holdings click here. For more ratings news on STR Holdings click here.
Shares of STR Holdings closed at $6.26 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Upgrades CAE Inc. (CAE:CN) (CAE) to Outperform
- Astellas Pharma Inc (4503:JP) (ALPMY) PT Raised to JPY2,500 at JPMorgan
- JPMorgan Upgrades PhysicsWallah Ltd (PWL:IN) to Overweight
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share